Kelly Bertram

Projects

Projects per year 2016 2019 2020 2022 2025

• 9 Active
• 10 Finished

Projects per year

Search results

• Active

  A Randomized, Double-Blind, Placebo-Controlled Study of ATH434 in Multiple Systems Atrophy

  Bertram, K.

  18/10/22 → 1/10/24

  Project: Research

• A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL TO ASSESS SAFETY AND EFFICACY OF SLS-005 (TREHALOSE INJECTION, 90.5 MG/ML FOR INTRAVENOUS INFUSION) FOR THE TREATMENT OF ADULTS WITH SPINOCEREBELLAR ATAXIA

  Bertram, K. & Paynter, C.

  28/07/22 → 2/12/24

  Project: Research

• Randomized, double-blind, placebo-controlled, multiple dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of YTX-7739, a novel oral inhibitor of Stearoyl-CoA-desaturases, in patients with Parkinson's Disease

  Bertram, K. & Kerris, J.

  1/06/21 → 31/12/23

  Project: Research

• An Open-label Extension of Study M15-736 to Evaluate the Safety and Tolerability of 24-hour Daily Exposure of ABBV-951 in Subjects with Advanced Parkinson's Disease.

  Bertram, K. & Burn, K.

  20/10/20 → 31/12/24

  Project: Research

• An open-label extension of Study M15-741 to evaluate the safety and tolerability of 24-hour daily exposure of continuous subcutaneous infusion of ABBV-951 in subjects with Parkinson's disease.

  Bertram, K., Fung, V. S. C., Hayes, M., Stell, R., Kimber, T. E. & Bonke, V.

  6/10/20 → 31/12/25

  Project: Research

• Sodium Selenate as a Disease Modifying Treatment for Progressive Supranuclear Palsy (Sodium Selenate for PSP)

  O'Brien, T., Bertram, K., Vivash, L., Evans, A. H., Kimber, T. E., O'Sullivan, J. D., Malpas, C., Fielding, J., Velakoulis, D. & Law, M.

  1/06/20 → 31/05/25

  Project: Research

• A 52-Week, open-label, single-arm study to evaluate the safety and tolerability of 24-hour daily exposure of continuous subcutaneous infusion of ABBV-951 in subjects with Parkinson's disease

  Bertram, K. & Burn, K.

  22/11/19 → 30/11/23

  Project: Research

• A Phase 2 Clinical Trial Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of PRAX-944 in Adults with Essential Tremor.

  Bertram, K., Fung, V. S. C., Lehn, A., Evans, A. H., Kotschet, K., Heshmat, S., Pepper, E. M. & Burn, K.

  1/06/19 → 31/12/24

  Project: Research

• Clinical Study No. M15-563, An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP).

  Bertram, K. & Burn, K.

  3/04/19 → 30/04/24

  Project: Research

• Finished

  Movement DIsorders 2022 Fellowship

  O'Brien, T. & Bertram, K.

  1/01/22 → 31/12/22

  Project: Research

• Educational Grant - Monash Alfred 2021 Movement Disorders Fellowship

  O'Brien, T. & Bertram, K.

  Ipsen (Australia)

  1/02/21 → 31/01/22

  Project: Research

• A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy, Safety and Tolerability of ABBV-951 to Oral Carbidopa/Levodopa in Advanced Parkinson's Disease Patients.

  Bertram, K. & Burn, K.

  1/11/20 → 30/11/22

  Project: Research

• Investigation of cervical muscle activation in chronic migraine and cervical dystonia with magnetic resonance imaging (MRI): a pilot study

  Hutton, E., Bertram, K., Williams, D., Thyagarajan, D., Law, M., Zhang, L., Kavnoudias, H., Kolbe, S. & Phua, C.

  21/10/20 → 21/04/22

  Project: Research

• A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120101 Administered Intrathecally in Patients with Huntington's Disease.

  O'Brien, T., Bertram, K. & Burn, K.

  18/09/19 → 31/10/21

  Project: Research

• A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120102 Administered Intrathecally in Patients with Huntington's Disease.

  O'Brien, T., Bertram, K. & Burn, K.

  18/09/19 → 31/10/21

  Project: Research

• A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Tolerability of GRF6021 Infusions in Subjects with Parkinson's Disease and Cognitive Impairment.

  Bertram, K. & O'Brien, T.

  8/04/19 → 30/04/20

  Project: Research

• REVIVER: The Assessment of a Novel Form of Exercise on Parkinsonism

  Sinclair, B., O'Brien, T., Bertram, K., Fielding, J., Clough, M. & White, O.

  Redmond Company Pty Ltd

  15/12/18 → 29/07/21

  Project: Research

• A Phase IIa, Randomized, Double Blind, Placebo Controlled, Single Ascending Dose, Safety and Pharmacokinetic / Pharmacodynamic Study of INP103 (POD L-dopa) Administered in the Presence of Benserazide to L-dopa Responsive Parkinson's Disease Patients.

  O'Brien, T. & Bertram, K.

  15/03/18 → 15/03/20

  Project: Research

• Transcranial Magnetic Stimulation in the diagnosis of Atypical Parkinsonism

  Bertram, K. & Williams, D.

  Parkinson's Victoria

  29/04/16 → 28/04/17

  Project: Research